Phase II study of weekly paclitaxel carboplatin in the treatment of progressive ovarian cancer.

被引:0
|
作者
Van der Burg, ME
Vergote, I
Burger, CW
van der Gaast, A
机构
[1] Univ Rotterdam, Erasmus MC, Med Ctr, Rotterdam, Netherlands
[2] Katholieke Univ Leuven Hosp, Louvain, Belgium
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5058
引用
收藏
页码:463S / 463S
页数:1
相关论文
共 50 条
  • [21] Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
    De Lena, M
    Lorusso, V
    Latorre, A
    Fanizza, G
    Gargano, G
    Caporusso, L
    Guida, M
    Catino, A
    Crucitta, E
    Sambiasi, D
    Mazzei, A
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (03) : 364 - 368
  • [22] Phase Ib/II with expansion of patients at the mtd study of olaparib plus weekly (metronomic) carboplatin and paclitaxel in relapsed ovarian cancer
    Rivkin, S. E.
    Iriarte, D.
    Sloan, H.
    Wiseman, C.
    Moon, J.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [23] Phase I/II dose-escalation and expansion study of afuresertib plus carboplatin and paclitaxel in recurrent ovarian cancer.
    Blagden, Sarah Patricia
    Gabra, Hani
    Hamilton, Anne L.
    Wong, Shirley S.
    Michael, Agnieszka
    Mileshkin, Linda R.
    Hall, Marcia
    Goh, Jeffrey
    Lisyanskaya, Alla Sergeevua
    DeSilvio, Michelle
    Habr, Dany
    Gainer, Shelby
    Gopalakrishna, Prashanth
    Meniawy, Tarek
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancer
    Berry, William
    Friedland, David
    Fleagle, John
    Jackson, Dori
    Ilegbodu, Des
    Boehm, Kristi A.
    Asmar, Lina
    CLINICAL GENITOURINARY CANCER, 2006, 5 (02) : 131 - 137
  • [25] Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study
    E van Meerten
    K Muller
    H W Tilanus
    P D Siersema
    W M H Eijkenboom
    H van Dekken
    T C K Tran
    A van der Gaast
    British Journal of Cancer, 2006, 94 : 1389 - 1394
  • [26] Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study
    van Meerten, E.
    Muller, K.
    Tilanus, H. W.
    Siersema, P. D.
    Eijkenboom, W. M. H.
    van Dekken, H.
    Tran, T. C. K.
    van der Gaast, A.
    BRITISH JOURNAL OF CANCER, 2006, 94 (10) : 1389 - 1394
  • [27] Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer
    Nishio, Shin
    Takekuma, Munetaka
    Takeuchi, Satoshi
    Kawano, Kouichirou
    Tsuda, Naotake
    Tasaki, Kazuto
    Takahashi, Nobutaka
    Abe, Masakazu
    Tanaka, Aki
    Nagasawa, Takayuki
    Shoji, Tadahiro
    Xiong, Hao
    Nuthalapati, Silpa
    Leahy, Terri
    Hashiba, Hideyuki
    Kiriyama, Tsukasa
    Komarnitsky, Philip
    Hirashima, Yasuyuki
    Ushijima, Kimio
    CANCER SCIENCE, 2017, 108 (11): : 2213 - 2220
  • [28] First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: A phase I study
    Sehouli, J
    Stengel, D
    Elling, D
    Ortmann, O
    Blohmer, J
    Riess, H
    Lichtenegger, W
    GYNECOLOGIC ONCOLOGY, 2002, 85 (02) : 321 - 326
  • [29] A PHASE 1 STUDY OF VELIPARIB WITH CARBOPLATIN AND WEEKLY PACLITAXEL IN JAPANESE SUBJECTS WITH NEWLY DIAGNOSED OVARIAN CANCER
    Takahashi, N.
    Nishio, S.
    Takeuchi, S.
    Takekuma, M.
    Abe, M.
    Tanaka, A.
    Kawano, K.
    Tsuda, N.
    Tasaki, K.
    Nagasawa, T.
    Shoji, T.
    Xiong, H.
    Leahy, T.
    Hashiba, H.
    Kiriyama, T.
    Komarnitsky, P.
    Shepherd, S.
    Ushijima, K.
    Hirashima, Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 835 - 835
  • [30] A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer - A Multicentre Italian Trial in Ovarian cancer (MITO-5) study
    Pignata, Sandro
    Breda, Enrico
    Scambia, Giovanni
    Pisano, Carmela
    Zagonel, Vittorina
    Lorusso, Domenica
    Greggi, Stefano
    De Vivo, Rocco
    Ferrandina, Gabriella
    Gallo, Ciro
    Perrone, Francesco
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (03) : 229 - 236